These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial. Richbourg HA; Mitchell CF; Gillett AN; McNulty MA BMC Vet Res; 2018 Mar; 14(1):105. PubMed ID: 29554967 [TBL] [Abstract][Full Text] [Related]
23. Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid. Rossini M; Viapiana O; Ramonda R; Bianchi G; Olivieri I; Lapadula G; Adami S Rheumatology (Oxford); 2009 Jul; 48(7):773-8. PubMed ID: 19406908 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and tolerability of i.m. disodium clodronate 200 mg/lidocaine 1%, given twice monthly, in comparison with i.m. disodium clodronate 100 mg/lidocaine 1%, given weekly, in healthy postmenopausal female patients. Radicioni M; Cremonesi G; Baraldi E; Leuratti C; Mariotti F Int J Clin Pharmacol Ther; 2013 Apr; 51(4):313-22. PubMed ID: 23357844 [TBL] [Abstract][Full Text] [Related]
25. Decreased periprosthetic bone loss in patients treated with clodronate: a 1-year randomized controlled study. Trevisan C; Ortolani S; Romano P; Isaia G; Agnese L; Dallari D; Grappiolo G; Cherubini R; Massari L; Bianchi G Calcif Tissue Int; 2010 Jun; 86(6):436-46. PubMed ID: 20390409 [TBL] [Abstract][Full Text] [Related]
26. Intramuscular clodronate therapy in postmenopausal osteoporosis. Rossini M; Braga V; Gatti D; Gerardi D; Zamberlan N; Adami S Bone; 1999 Feb; 24(2):125-9. PubMed ID: 9951781 [TBL] [Abstract][Full Text] [Related]
27. Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. McCloskey EV; Beneton M; Charlesworth D; Kayan K; deTakats D; Dey A; Orgee J; Ashford R; Forster M; Cliffe J; Kersh L; Brazier J; Nichol J; Aropuu S; Jalava T; Kanis JA J Bone Miner Res; 2007 Jan; 22(1):135-41. PubMed ID: 17042717 [TBL] [Abstract][Full Text] [Related]
28. Chronic calcific periarthritis of the elbow treated by cimetidine administration: Five cases. Kimura H; Iwamoto T; Oki S; Matsumura N; Nakamura M; Matsumoto M; Sato K J Orthop Surg (Hong Kong); 2017; 25(2):2309499017717193. PubMed ID: 28659055 [TBL] [Abstract][Full Text] [Related]
29. The use of bisphosphonates in palliative treatment of bone metastases in a terminally ill, oncological elderly population. Santangelo A; Testai M; Barbagallo P; Manuele S; Di Stefano A; Tomarchio M; Trizzino G; Musumeci G; Panebianco P; Maugeri D Arch Gerontol Geriatr; 2006; 43(2):187-92. PubMed ID: 16325938 [TBL] [Abstract][Full Text] [Related]
30. Hydroxyapatite pseudopodagra in a young man: acute calcific periarthritis of the first metatarsophalangeal joint. Mines D; Abbuhl SB Am J Emerg Med; 1996 Mar; 14(2):180-2. PubMed ID: 8924143 [TBL] [Abstract][Full Text] [Related]
31. [Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates]. Endo Y; Funayama H; Yamaguchi K; Monma Y; Yu Z; Deng X; Oizumi T; Shikama Y; Tanaka Y; Okada S; Kim S; Kiyama T; Bando K; Shima K; Suzuki H; Takahashi T Yakugaku Zasshi; 2020; 140(1):63-79. PubMed ID: 31902887 [TBL] [Abstract][Full Text] [Related]
32. Use of clodronate for painful knee prosthesis in osteoarthritis patients: a 6-month pilot study. Saviola G; Ferrari P; Niccolò E; Casabella A; Ghellere F; Bonazzi S; Lul AA; Comini L; Molfetta L Minerva Med; 2020 Dec; 111(6):551-559. PubMed ID: 32573517 [TBL] [Abstract][Full Text] [Related]
33. Can fall risk be incorporated into fracture risk assessment algorithms: a pilot study of responsiveness to clodronate. Kayan K; Johansson H; Oden A; Vasireddy S; Pande K; Orgee J; Kanis JA; McCloskey EV Osteoporos Int; 2009 Dec; 20(12):2055-61. PubMed ID: 19436939 [TBL] [Abstract][Full Text] [Related]
34. [Clodronate in erosive osteoarthrosis of the hand: efficacy for pain and function recovery]. Saviola G; Santoro L G Ital Med Lav Ergon; 2000; 22(4):328-31. PubMed ID: 11284157 [TBL] [Abstract][Full Text] [Related]
35. First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Morgan GJ; Davies FE; Gregory WM; Cocks K; Bell SE; Szubert AJ; Navarro-Coy N; Drayson MT; Owen RG; Feyler S; Ashcroft AJ; Ross F; Byrne J; Roddie H; Rudin C; Cook G; Jackson GH; Child JA; Lancet; 2010 Dec; 376(9757):1989-99. PubMed ID: 21131037 [TBL] [Abstract][Full Text] [Related]
36. Clodronate in the prevention and treatment of skeletal metastasis. Gulley J; Dahut WL Expert Rev Anticancer Ther; 2005 Apr; 5(2):221-30. PubMed ID: 15877520 [TBL] [Abstract][Full Text] [Related]
37. Further analysis of the survival benefit of clodronate. Aragon-Ching JB Cancer Biol Ther; 2009 Dec; 8(23):2221-2. PubMed ID: 19855155 [TBL] [Abstract][Full Text] [Related]
38. Comparison of different treatment modalities for postmenopausal patients with osteopenia: hormone replacement therapy, calcitonin and clodronate. Tiraş MB; Noyan V; Yildiz A; Biberoğlu K Climacteric; 2000 Jun; 3(2):92-101. PubMed ID: 11910657 [TBL] [Abstract][Full Text] [Related]
39. Effects of two administration schemes of intramuscular clodronic acid on bone mineral density: a randomized, open-label, parallel-group study. Frediani B Clin Drug Investig; 2011; 31(1):43-50. PubMed ID: 20932069 [TBL] [Abstract][Full Text] [Related]
40. Treatment of painful bone lesions and hypercalcemia. Ascari E; Attardo-Parrinello G; Merlini G Eur J Haematol Suppl; 1989; 51():135-9. PubMed ID: 2534078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]